Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization

NCT03300401 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Accrual issue

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Perflutren Lipid Microspheres
DRUG: Sulfur Hexafluoride Lipid Microspheres
DEVICE: Dynamic Contrast-Enhanced Ultrasound Imaging
DEVICE: Positron Emission Tomography
DEVICE: Computed Tomography
BIOLOGICAL: Yttrium-90 (90Y)

Sponsor

University of Southern California

Collaborators

[object Object]